MAXCLINIC HYALURONIC MESO CHANGE

Manufacturer
N&B LAB.Co.Ltd
Effective date
2017-03-14
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:17:42

Label at a glance#

ProductMAXCLINIC HYALURONIC MESO CHANGE ROLLER
Active ingredientHYALURONIC ACID
Label structure8 sections

Dosage and administration

Directions: 1. First place the handle on the roller, then remove the protective cap. 2. Gently roll across the entire face for absorption. For optimal results, start rolling from areas with deep wrinkles (neck, smile lines, forehead). 3. Use for 3~5 minutes until the hyaluronic acid melts into the skin and then the roller becomes blunt. * First apply the ampoule on the face and neck, then use the roller. * Intende...

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Hyaluronic acid 97.0%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Lactose

PURPOSE

OTC - PURPOSE SECTION

Purpose: Skin Firming & Moisturizing

WARNINGS

WARNINGS SECTION

Warnings: For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

Directions

INDICATIONS & USAGE SECTION

Directions: 1. First place the handle on the roller, then remove the protective cap. 2. Gently roll across the entire face for absorption. For optimal results, start rolling from areas with deep wrinkles (neck, smile lines, forehead). 3. Use for 3~5 minutes until the hyaluronic acid melts into the skin and then the roller becomes blunt. * First apply the ampoule on the face and neck, then use the roller. * Intended for a single use only. Please remove and discard the roller after use. * Once opened, use immediately

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage & Administration: Use once a week.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69058-600-022024-12-09C16284748780-19d75b9d0-553f-f424-e053-dadaa90a57cea302ac3b-043a-411e-982a-75373ec651b9
69058-600-022020-01-31C16284748780-19d75b9d0-553f-f424-e053-dadaa90a57cea302ac3b-043a-411e-982a-75373ec651b9

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69058-60069058-600-01, 69058-600-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
HYALURONIC ACIDS270N0TRQYACTIB
LactoseJ2B2A4N98GIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
28d05530-d00f-9587-e063-6294a90a7d8fa302ac3b-043a-411e-982a-75373ec651b92024-12-09WarningsExact identifier
spl set id: a302ac3b-043a-411e-982a-75373ec651b9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.